Purpose: CBCT-based adaptive radiotherapy requires daily images for accurate dose calculations. This study investigates the feasibility of applying a single convolutional network to facilitate CBCT-to-CT synthesis for head-and-neck, lung and breast cancer patients. Methods: Ninety-nine patients diagnosed with head-and-neck, lung or breast cancer undergoing radiotherapy with CBCT-based position verification were included in this study. CBCTs were registered to planning CTs according to clinical procedures. Three cycle-consistent generative adversarial networks (cycle-GANs) were trained in an unpaired manner on 15 patients per anatomical site generating synthetic-CTs (sCTs). Another network was trained with all the anatomical sites together. Performances of all four networks were compared and evaluated for image similarity against rescan CT (rCT). Clinical plans were recalculated on CT and sCT and analysed through voxelbased dose differences and γ-analysis. Results: A sCT was generated in 10 seconds. Image similarity was comparable between models trained on different anatomical sites and a single model for all sites. Mean dose differences < 0.5% were obtained in high-dose regions. Mean gamma (2%,2mm) pass-rates > 95% were achieved for all sites. Conclusions: Cycle-GAN reduced CBCT artefacts and increased HU similarity to CT, enabling sCT-based dose calculations. The speed of the network can facilitate online adaptive radiotherapy using a single network for head-and-neck, lung and breast cancer patients.
I. Introduction
In modern external beam image-guided radiotherapy (IGRT), cone-beam computed tomography (CBCT) plays a crucial role in accurate patient position verification 1, 2, 3 . Also, CBCT can facilitate adaptive radiotherapy (ART) by visualising daily anatomical variations 4, 5 .
CBCT image quality is inferior to that of CT in soft-tissue contrast and Hounsfield Units (HU) consistency due to the presence of artefacts 6, 7, 8 . Therefore, CBCT is not sufficient to perform accurate dose calculations 9 and patients need to be referred for a rescan CT (rCT) whenever anatomical differences are noted between daily images and planning CT 10 .
However, scheduling and acquiring a rCT adds logistic complexity and patient burden to the treatment. On the contrary, with ART these issues can be addressed by exploiting the daily CBCT images to reduce set-up errors and eliminate the need for an rCT 5 . A prerequisite for online ART is that the CBCT quality and HU accuracy is sufficient to enable dose calculation.
Considerable literature has recently emerged proposing to correct CBCT imaging artefacts and increase image intensity consistency using: look-up table-based approaches 11, 12 , deformable imaging registration (DIR) of the planning CT to the daily anatomy on CBCT 13, 14, 15 and model-or Monte Carlo-based methods for scatter estimation and correction 16, 17, 18 . Specifically, DIR enabled accurate dose calculations for head-and-neck (HN) 19 but obtained lower dose accuracy in more complex anatomical changes such as lung 15 and pelvis 20, 21 . Also, Monte Carlo-based methods were suitable for ART 20, 22, 23 . These techniques can be deployed on a time scale of minutes, which is not acceptable when aiming to use CBCT images for daily online dose evaluation or online pre-treatment adaptation.
Recently, deep learning has been proposed for fast CBCT artefact correction 24, 25, 26, 27, 28, 29 . Deep learning is a branch of artificial intelligence and machine learning that involves the use of neural networks to generate a hierarchical representation of the input data to achieve a specific task without the need of hand-engineered features 30, 31 . Deep learning has shown promising results solving image-to-image translation problems within seconds 32, 33 . In this sense, previous work demonstrated the use of a two-dimensional (2D) U-net to improve CBCT image quality 24, 25, 26 . Moreover, it has been shown that converting CBCT with deep learning resulted in accurate dose calculation for prostate cancer patients 27, 29 and HN cancer patients 28, 34 .
In this study, we investigate whether CBCTs converted with convolutional networks may be used as a surrogate of the daily anatomy for dose calculations. We employ a network trained in an unpaired manner to convert CBCT-to-CT of HN, lung, or breast cancer patients investigating whether a single network can generalise for the three anatomical sites. A single network trained for all the anatomical sites was compared to three networks trained per anatomical site. Performances of all four networks were compared and evaluated for image similarity and dose calculation accuracy between CT and rCT.
II. Material and methods

II.A. Imaging protocols
Ninety-nine patients diagnosed with HN (33), lung (33) or breast (33) cancer undergoing radiotherapy were retrospectively included in this study. Irradiations were performed between May 2016 and February 2019 on Agility linacs (Elekta AB, Sweden) with CBCT-based pre-treatment position verification.
An rCT was acquired in case anatomical variations were noted on the CBCT. We included at least fourteen patients with rCT per site.
The (r)CTs were acquired on a Brilliance Big Bore (Philips Healthcare, Ohio, USA); CBCTs were acquired using X-ray volumetric imaging (XVI, v5.0.2b72 Elekta AB, Sweden) system. Table 1 reports the imaging protocols for CT, rescan CT (rCT) and CBCT for all the patients included in the study. CBCTs were acquired with 0.25 rotation/s gantry speed and Imaging frequency of CBCT followed the extended non-action limit protocol 35 : online corrections (action level 0 mm) were applied in the case of partial or ablative breast irradiation, and offline long (N=3, P=5) and short (N=2, P=3) scheme were applied for irradiations II. MATERIAL AND METHODS Table 1 : Overview of CT (including also rescan (r)CT) and CBCT imaging protocols in terms of field-of-view (FOV), acquisition matrix (Acq matrix), resolution (Res), tube voltage (kVp), exposure (ms) and current (mA). For exposure and current, the mean value (±σ) was reported along with the range. having > 20 and < 20 fractions, respectively. Imaging frequency may have been increased after consultation between a medical physicist and a radiotherapist on a single patient-basis in case large inter-fraction motions were observed in the initial fractions or whenever RT technicians reported difficulties in reproducing the planning position.
CBCTs were translated to apply clinical set-up corrections and resampled to the planning CT within the X-ray volumetric imaging (XVI, v5.0.2b72 Elekta AB, Sweden) system.
Registrations were estimated within a clip-box including the CTV based on bone rigid (translation and rotation) matching 36 . For the breast patients treated with local RT followed by a sequential boost, a dual rigid registration was performed based first on bone matching followed by grey level (soft-tissue) matching 37, 38 . The centre of rotation was assigned as the centre of the PTV. Before supplying images to the network, CT and CBCT were cropped to the size of the CBCT FOV after identifying the so-called "Mask CBCT " according to the following steps. CBCTs were thresholded at -999.9, obtaining a binary mask. In each transverse slice containing the binary mask, morphological closure was performed, and the smallest bounding box containing the mask was found. The biggest circle contained in the bounding box was searched starting from a radius of 26.9 cm and iteratively increasing its size. The circle was propagated for all the slices obtaining Mask CBCT . CT and CBCT were cropped in the bounding box containing
In addition to cropping, voxel intensity of CT and CBCT were clipped within the interval [−1000;3071] HU and image intensity was linearly rescaled to 16-bit.
II.B.2. Network architecture and training
To generate CT from CBCT, a 2D cycle-generative adversarial network (cycle-GAN) was adopted 39 . Cycle-GANs enable unpaired training, which, compared to paired training, makes the network less sensitive to residual mismatch of CT and CBCT 40 .
The network consisted of two cycles called "forward" and "backwards" during which GANs generated CT from CBCT and vice-versa. Moreover, so-called "cycle-consistency" was enforced with an L 1 -norm such that after converting from CBCT to CT and vice-versa, the original image should be obtained. The architecture, based on the cycle-GAN provided by Zhou et al. 39 , was implemented in Tensorflow (v1.3.0). Nine-blocks residual networks 41 were employed as generators and Patch-GANs 42 as discriminators ( Figure 1 ). Stochastic gradient descendent was used applying an Adam solver 43 with learning rate = 0.0002, momentum parameters β 1 = 0.5 and β 2 = 0.999. Instance normalisation 44 was employed with a batch size of 1. The weights of the network were randomly initialised from N (0, 0.02). Weight optimisation was performed as in Goodfellow et al. 45 alternating between one gradient descendent step on the discriminator network and one step on the generator network after having performed a forward and backward cycle. A structured loss function GAN+λ · L 1 +cycleconsistency with λ = 25 was adopted. The original implementation of the network by Zhou II. MATERIAL AND METHODS II.B. CBCT-to-CT synthesis was restored with a linear rescaling obtaining the so-called CBCT conv . CBCT conv were bi-linearly resampled from a matrix size of 256x256 to the original CBCT resolution.
To generate images for the full CT FOV, the CBCT conv was substituted in the original CT within the Mask CBCT . The image obtained combining CT and CBCT conv will be referred to as synthetic-CT (sCT) (Figure 2 ).
II. MATERIAL AND METHODS II.B. CBCT-to-CT synthesis 
II.C. Evaluation
Image evaluation in terms of similarity between sCT and rCT was performed to assess whether the single network trained with all the anatomical sites was comparable to the three networks trained per anatomical site. If performances were comparable, the single network was considered to assess the appropriateness of the CBCT conversion with the trained cycle-GAN on the test set with an image and a dose comparison.
II.C.1. Image comparison
Similarities between the image intensity of sCT, CBCT, CT and rCT were calculated within Mask CBCT in terms of mean absolute error (MAE) and mean error (ME) as proposed by Liang et al. 28 . Rescan CT was considered as ground truth, and the metrics were calculated in terms of mean ±1σ and range. Wilcoxon signed-rank tests were conducted between sCT/rCT and CT/rCT for MAE. Additional metrics are reported in Supplementary Material. Table 2 . 
III. Results
III.A. Network
Generic network vs site-specific networks
No statistically significant differences (p>0.35) were found between networks trained per separate anatomical site and the single network trained with all three anatomical sites. This justifies the use of the single model trained for all the anatomical sites for assessing the accuracy of HU and for the dose comparison.
Accuracy of HU
One can notice that similarity increased between sCT and rCT compared to CBCT and rCT; e.g. MAE decreased from 195±20 (CBCT/rCT) to 53±12 HU (sCT/rCT) for HN. All the similarity metrics calculated between sCT/rCT and CT/rCT can be considered equivalent Last edited: December 25, 2019 to the metrics calculated between CT and rCT, with no significant differences (p>0.14) for all the three anatomical sites. The mean MAE and range for sCT/rCT were smaller than for CT/rCT due to the reduced time between sCT/rCT, which resulted in less anatomical differences. The mean gamma pass rates with the 2%,2mm criteria were higher for sCT/rCT compared to CT/rCT for all VOIs, which is in line with the dose differences observed. All DVH points differed on average <0.5% compared to rCT. DVH points differences were < 2% except for the heart of a breast patient (B31, -5.6%), the oesophagus of two breast patients (B30, 3.1% and B31, 2.3%), left lung and spinal cord of two lung patients (L25, -2.1% and L27, 3.8%, respectively). Images of the patients with doses differences in VOIs > 2% were inspected on a single-case basis, as reported in the Supplementary Material. We noticed that large dose differences were in low-dose regions, which are more sensitive to statistical differences due to the low amount of events in the Monte Carlo dose calculations. For a lung case (L25), anatomical differences were reported as the cause of the observed differences.
III.C. Dose comparison
Also, residual artefacts characterised by inhomogeneous HUs seem to be present along the craniocaudal direction in the lungs for sCT; it appears that for this case the CBCT artefacts were not fully recovered by the network within the lungs. Also for the other lung case (L27), anatomical differences were observed in the lung. In addition, we noticed the patient was obese and the CBCTs were characterised by severe scatter artefacts. On sCT, the spinal cord was not entirely recovered, possibly resulting in local difference. Besides, the spinal cord is located in a low-dose region, which may be highlighted when considering metrics as voxel-wise relative differences. 
IV. Discussion
Cycle-consistent generative adversarial network (cycle-GAN) increased the accuracy of HU in CBCT, enabling sCT-based calculations for HN, lung and breast cancer patients. Also, we found that a single network trained on all the three sites performed similarly to three networks trained on each anatomical site.
When investigating the accuracy of HU on sCT calculating image similarity to rescan CT, we found that HU values were comparable to values observed between CT and rCT.
We observed a slight increase in performance for HN compared to breast and lung cancer patients. The network was trained with higher amount of slices for HN (1606) compared to lung and breast (1046 and 1016, respectively). We hypothesise that this data imbalancing may have resulted in relatively increased perfomances for HN cancer patients. Also, the use of immobilisation masks for HN case may increase the reproducibility of patient setup or reduce motion artefacts in the images (both CT and CBCT) 48 . Though variations in the CBCT imaging protocol were reported, e.g. kV, mAs and linac where the images were acquired, we did not observe any effect on the quality of sCT. It may be of interest to investigate thoroughly the influence to the robustness of the method to variations of acquisition settings, as already proposed by Maier et al. 26 .
In terms of dose calculation accuracy, we compared sCT to rCT, achieving excellent results for all the anatomical sites. Previous work with deep learning was performed on prostate 24, 27, 29, 49 Repositioning inevitably occurred between CBCT, rCT and CT. To further minimise anatomical and set-up differences, we could have recurred to deformable image registration (DIR) to increase the similarity of CBCT/sCT and CT/rCT. However, we opted against it for the following reasons: (i) since we were trying to reproduce the dose derived by CTbased calculations, we did not want to modify CT or rCT further; (ii) residual deformation errors should be thoroughly evaluated 51 , and this was deemed out of the scope of this investigation; (iii) recurring to using solely translation mimics the set-up procedure that is currently performed clinically at the linacs, and we aimed at observing the impact of dose evaluation in a comparable setting.
The main limitation of this study is deemed to be the cohort size: ten patients per anatomical sites in the test set may be considered as a low number. Before clinical implementation, a study including a larger number of patients should be initiated, paying particular attention to the data variability and data balancing among anatomical sites. Besides, we did not adapt the contours of targets and OARs, which is necessary to investigate the clinical impact of replanning thoroughly. To our knowledge, this is the most extensive study so far presented utilising a convolutional neural network for sCT generation with ninety-nine included patients. Also, notwithstanding the relatively limited sample, this work offers valuable insights into the generalisation capability of a single cycle-GAN, and, in general, in showing that a single neural network can convert CBCTs of multiple sites.
Currently, we balanced the sites based on the number of patients performing training with about 1.5 times more images for HN compare to lung and breast patients. It would be interesting to investigate in a future study whether different balancing may maintain comparable image similarity for all the anatomical sites. We believe that further improvements can be made by balancing data in terms of the number of slices included in the training.
In our study, we showed, for the first time, that a single cycle-GAN can be utilised for multiple anatomical sites as HN, breast and lung. This finding has important implications for simplifying the training of a convolutional network since a single network may be adopted for different anatomical sites. To fully understand whether a single network may facilitate CBCT-based dose calculations for the whole body, we are currently performing a novel study including additional anatomical areas, e.g. pelvis, lower abdomen and brain.
The impact of our work is that with a single cycle-GAN CBCTs were converted into CTs, resulting in sCTs that have sufficient quality to enable dose planning. Also, conversion occurred in a matter of seconds, which is line with the sCT generation time reported by IV. DISCUSSION other deep learning approaches for lung 25 , prostate 27, 29, 49 and HN 28, 50 . We foresee these as an important step toward online ART. In conventional non-adaptive radiotherapy, this methodology can be used to evaluate the dosimetric impact of anatomical differences occurring during treatment, supporting the decision to perform a rescan CT or not.
In conclusion, a single cycle-GAN was successfully trained to convert CBCT to CT using unpaired training data of HN, breast and lung cancer patients. The resulted sCT resembled a diagnostic quality planning CT and featured the anatomy of the daily CBCT.
In terms of dose calculation accuracy, good results were obtained for all the anatomical sites.
In general, the proposed approach enables considerably fast image conversion, and it may facilitate online adaptive radiotherapy treatments.
